Quince Therapeutics, Inc. - Common Stock (NQ: QNCX )
0.6910
-0.0023
(-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Quince Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2024/08/19/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/16/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240815940181/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240813990780/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240625494765/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240603425785/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240513538230/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240506671205/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240329372032/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240222393006/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Launches Scientific Advisory Board
February 22, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240215193487/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240207118051/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20240104212468/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/12/08/image27.jpeg?width=1200&height=800&fit=crop)
SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
December 08, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/04/image14.jpg?width=1200&height=800&fit=crop)
Over $2M Bet On This Industrial Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
December 04, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://mms.businesswire.com/media/20231023815692/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Completes Acquisition of EryDel S.p.A.
October 23, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image31.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230928420547/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230906220898/en/1528430/22/Quince_Therapeutics_Logo.jpg)
Quince Therapeutics Appoints Dr. Charles S. Ryan as President
September 06, 2023
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/08/14/image_7.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230810799693/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/qncx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/image14.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230724507851/en/1528430/22/Quince_Therapeutics_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.